All In MedTech

FDA Clearance Tracker · P150031-S005

Vercise DBS System / Vercise PC DBS System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 23, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 23, 2018

Approved

Time to decision

182 days

Received Feb 22, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150031-S005
Device name
Vercise DBS System / Vercise PC DBS System
Applicant location
Valencia, CA
Received
Feb 22, 2018
Decided
Aug 23, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P150031

Device type

Device class
Class III

Every decision under product code NHL

FDA's approval statement

As written in FDA's record.

Approval for MR-Conditional labeling for the DBS leads-only system for the DB-2201-xx leads and lead accessories.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.